Neudle.com: drug interactions

Differential
(Click to cross reference)

abdominal protrusion

acetaminophen

acetylcholine

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acromegaly

acupuncture

acyclovir

advances in neurology

adverse drug reaction

alpha methyldopa hydrazine

alpha-fetoprotein

alternative medicine

Alzheimer's disease

Alzheimer's disease, treatment of

amphetamines, dyskinesia associated with

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, treatment of

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticoagulant, discontinuation

anticoagulant, reversal of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, mechanism of action of

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

artificial intelligence

aspartate aminotransferase

atrioventricular block

atypical

autonomic dysfunction

beta adrenergic blocker

calcium antagonist, side effects of

carbamazepine

carbamazepine, controlled release

carbamazepine, toxicity

carbidopa

cardiovascular disease

carnitine deficiency

case studies

CAT scan, angiography

CAT scan, emission

catechol-o-methyltransferase inhibitor

CD4 counts

cerebellar hemorrhage

cerebral embolism, cardiac origin

cerebral ischemia

cerebrovascular accident

cerebrovascular accident, prevention of

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest pain

children

chiropractic manipulation

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

Coombs test, positive

coronary artery disease

coronary artery spasm

creatine phosphokinase(CPK)elevated

dementia, treatment of

deprenyl

depression

desipramine

dexamethasone suppression test

dilantin, factors influencing metabolism of

dilantin, saliva level

dilantin, serum level

drug induced neurologic disorders

drug interactions

drug overdose

drug overdose, management of

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dyspepsia

dyspnea

dystonia

dystonia, treatment of

Echinacea

efficacy

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

electromyogram

embolism, silent

emergencies, neurologic

epidemiology of neurology

epilepsy referral centers

evidence-based research

gamma amino butyric acid-mimetic drug

gangrene

gastrointestinal bleeding

gemfibrozil

gender

Generative Pretrained Transformer 4

generic drugs

genetic neurologic disorders

genetic testing

ginkgo biloba

ginseng

globus pallidus, stimulation

glucose tolerance test, abnormal

groaning

hallucination

hallucination, visual

haloperidol

headache

headache, treatment of

heart block

heart valve, prosthetic

histamine-2 receptor blockers

HMGcoA reductase inhibitors

human immunodeficiency virus type 1

hypotension, systemic

iatrogenic neurologic disorders

imipramine

immunosuppression

inappropriate antidiuretic(A.D.H.)hormone

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, plasma concentration

L-dopa, potentiators of

Lennox-Gastaut syndrome

Lewy body disease, diffuse

liver function enzymes

locus ceruleus, lesion of

memory, impairment of

mental status, abnormal

microhemorrhage, intracerebral

migraine

migraine, prophylaxis

migraine, treatment of

misdiagnosis

mitochondrial disease

modafinil

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

multiple sclerosis

multiple sclerosis, treatment of

myasthenia gravis, diagnosis

myasthenia gravis, misdiagnosis of

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myocardial infarction

myocardial infarction, acute

myopathy, drug-induced

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologist

neuromuscular blockade

neuronal degeneration

nigrostriatal pathway

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

nortriptyline

number needed to treat

olanzapine

old age, neurology of

oral contraceptives, choreiform movements with

organ transplantation

orthostatic hypotension

pain, management of chronic

parietal lobe, lesion of

Parkinson disease

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, fluctuations in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, young onset

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

patient information and support

pergolide

peripheral pulse, absent

phenothiazine, dyskinesia associated with

phobias

platelet inhibiting drugs

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

procyclidine

prognosis

progressive supranuclear palsy

propoxyphene

protease inhibitor, HIV-1

proton pump inhibitors

psychiatric disorder

psychiatric problems in neurologic disorders

pupil, dilated, bilateral

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respirator

respiratory dyskinesias

respiratory failure

respiratory paralysis, pharmacologic

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug resistance

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, neonatal

seizure, non-treatment of

seizure, paradoxical

seizure, pregnancy

seizure, prognosis in adults

seizure, psychomotor-temporal lobe

seizure, remission

seizure, surgical treatment of

seizure, systemic disease causing

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, women

selective serotonin reuptake inhibitors

serum alanine aminotransferase

shivering

simvastatin

sinemet

single photon emission computed tomography

sinus arrest

skin, discoloration

sleep pathology and physiology

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

spasticity

spasticity, treatment of

spina bifida

spinal cord, injury of

St. John's wort

start hesitation

statin therapy

statin therapy, discontinuation

statin therapy, dose

status epilepticus

status epilepticus, nonconvulsive

stimulation, deep brain

stress management

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

temporal lobe, status

teratogenesis

teratogenic drugs

tetrahydroaminoacridine

thrombotic thrombocytopenia purpura

transient ischemic attack

trazodone

treatment of neurologic disorder

tremor

tremor, thalamic stimulation for suppression of

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, treatment of

triglycerides

triptans

ultrasonography

ultrasonography, head, fetus-neonate

uremia

urine, dark

vagus nerve stimulation

venous thrombosis, non-cerebral

voice, abnormality of

Showing articles 50 to 100 of 6670 << Previous Next >>

Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000

Quetiapine for L-Dopa-Induced Psychosis in PD
Neurol 54:1538, Weiner,W.J.,et al, 2000

A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000

Adverse Effect of Anticonvulsants on Efficacy of Chemotherapy for Acute Lymphoblastic Leukaemia
Lancet 356:285-290, Relling,M.V. et al, 2000

Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000

Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999

Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999

Drug Interactions with Methadone
Presse Med 27:1381-1384, Schlatter,J.,et al, 1999

Herbal Remedies: Adverse Effects and Drug Interactions
Am Fam Physician 59:1239-1244, Cupp, M.J.,et al, 1999

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998

New Antiepileptic Drugs
Arch Neurol 55:1181-1183, Bourgeois,B.F.D., 1998

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998

Tiagabine
Lancet 351:203-207, Leach,J.P.&Brodie,M.J., 1998

An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998

Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter 40:59-60, , 1998

Fiddleheads and the International Normalized Ratio
NEJM 338:1550, Bartle,W.R.&Ferland,G., 1998

Gabapentin Does Not Interact with a Contraceptive Regimen of Norethindrone Acetate and Ethinyl Estradiol
Neurol 50:1146-1148, Eldon,M.A.,et al, 1998

Lamotrigine for Generalized Seizures Associated with the Lennox-Gestaut Syndrome
NEJM 337:1807-1812, Motte,J.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997

Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997

Low-Dose Clozapine Improves Dyskinesias in Parkinson's Disease
Neurol 48:658-662, Durif,F.,et al, 1997

Seizures in Medically Complex Patients
Epilepsia 38:S55-S59, Boggs,J.G., 1997

The Clinical Relevance of the Interaction Between Carbamazepine and Dextropropoxyphene in Elderly Patients in Gotenburg, Sweden
Europ J Clin Pharm 53:203-206, Bergendal,L.,et al, 1997

Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997

Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996

New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996

Antiepileptic Medication and Oral Contraceptive Interactions:A National Survey of Neurologists and Obstetricians
Neurol 46:1534-1539, Krauss,G.L.,et al, 1996

Riluzole
Lancet 348:795-799, Wokke,J., 1996

Acute Phenytoin Toxicity Followed by Seizure Breakthrough From a Ticlopidine-Phenytoin Interaction
Arch Neurol 53:1191-1192, Privitera,M.&Welty,T.E., 1996

Gabapentin Interaction with Felbamate
Neurol 47:1106, Hussein,G.,et al, 1996

Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996

Ticlopidine Impairs Phenytoin Clearance:A Case Report
Neurol 46:1172-1173, Riva,R.,et al, 1996

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995

Serotonin Syndrome
Neurol 45:219-223, Bodner,R.A.,et al, 1995

Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Tacrine
Lancet 345:625-630, Davis,K.L.&Powchik,P., 1995

Risperidone
Lancet 343:457-460, Livingston,M.G., 1994

Showing articles 50 to 100 of 6670 << Previous Next >>